glp-1/glp-2 dual agonist GLP-1 receptor agonists Mechanisms of action of GLP-1

OBrien R, OMalley D

Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes, January 2022, Faillie et al

Trapp, S

[PubMed] [Google Scholar] [47].Thum A, Hupe-Sodmann K, Goke R, Voigt K, Goke B, McGregor GP, Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and 4, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 110 (2002) 113118

Contact us today to request an appointment and learn more about how we can support your digestive health

Current clinical evidence supports the safety of GLP-1 medications over extended periods, with large trials running up to several years showing sustained benefits and a well-characterized side effect profile